[Psychosomatic medicine--the future of an illusion].

Psychother Psychosom Med Psychol

Université de Liège, Département Psychologie Médicale et Psychiatrie Dynamique, Belgien.

Published: November 1994

This paper presents the phenomenology and the development of theories about alexithymia, a "behavioral neurosis" in psychosomatic patients, with background of the american (F. Alexander, R. Grinker and P. Knapp) and french (P. Marty) psychosomatic schools. Luminet's understanding comprises the combination of an object-relations-theory perspective of alexithyma with the clinical theory of "depréssion essentielle" of Marty. Primary and secondary shortcomings and dysregulations in the early mother-child-relation lead to essential insecurity in building up stable self and object representations with a specifically reduced libidinal tonus of the self and dependency of objects. These conditions lead to the formation of alexithymic disturbances in thought, interaction and object relations, as well as to impaired capacity for self reflection in perception and evaluation of affects, which do not become available as signals for the ego-functions. Moreover, as the capacity for self regulation, as a function of maternal care, could not be internalized, there is an increased proneness for somatisation. In literature, these characteristics were commonly taken for the main limitations for the success of psychoanalytic or psychodynamic treatments. Luminet's psychotherapeutic access in the treatment of alexithymic patients is based on activation and differentiation of the self and object representations through verbal and nonverbal techniques, aiming on actualisation and development of maternal functions; this implies the acknowledgement of the physical body within the therapeutic relationship and awareness of specific counter-transference reactions.

Download full-text PDF

Source

Publication Analysis

Top Keywords

object representations
8
[psychosomatic medicine--the
4
medicine--the future
4
future illusion]
4
illusion] paper
4
paper presents
4
presents phenomenology
4
phenomenology development
4
development theories
4
theories alexithymia
4

Similar Publications

Background: Episodic memory declines during healthy aging and is often reported as an early symptom of Alzheimer's disease (AD). However, standardized assessments of memory performance are limited in their accuracy to predict progression of early-stage AD pathology. The 'all-or-none' approach commonly used in neuropsychological assessment for quantifying memory performance might miss out on subtle variation in the fidelity or quality mnemonic representations retrieved from memory.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Memory Resources and Research Center, CHRU Gui de Chauliac, Montpellier, France.

Background: Microbiota is modulated by normal aging, but also by Alzheimer's disease (AD) risk factors as poor diet or alteration of sleep patterns. Patients with AD exhibit a dysbiosis characterized by changes in the relative proportions of specific bacterial phyla. Eventually, fecal microbiota transplants (FMT) can improve cognitive deficits and reduce amyloid-ß deposition, at least in mouse models of AD.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Institute of Cognitive Neurology and Dementia Research (IKND), Otto von Guericke University, Magdeburg, Germany.

Background: Episodic memory declines in old age. Successful memory relies on the process of mnemonic discrimination (MD) to establish distinct representations. However, the scope for improvement in older adults' cognitive performance using cognitive training is poorly understood.

View Article and Find Full Text PDF

Background: Alzheimer's Disease (AD) is characterized by progressive impairment of cognition and memory, including the loss of episodic memory. The use of non-invasive brain stimulation therapies to modulate memory encoding processes is a promising avenue for potential treatment. Previous studies have shown that the use of Transcranial Magnetic Stimulation (TMS) applied to lateral parietal cortex can improve memory in older adults who have received a diagnosis of Mild Cognitive Impairment.

View Article and Find Full Text PDF

Background: Episodic memory declines during healthy aging and is often reported as an early symptom of Alzheimer's disease (AD). However, standardized assessments of memory performance are limited in their accuracy to predict progression of early-stage AD pathology. The 'all-or-none' approach commonly used in neuropsychological assessment for quantifying memory performance might miss out on subtle variation in the fidelity or quality mnemonic representations retrieved from memory.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!